Literature DB >> 18825165

FXR: a metabolic regulator and cell protector.

Yan-Dong Wang1, Wei-Dong Chen, David D Moore, Wendong Huang.   

Abstract

Farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily of ligand-activated transcription factors. As a metabolic regulator, FXR plays key roles in bile acid, cholesterol, lipid, and glucose metabolism. Therefore, FXR is a potential drug target for a number of metabolic disorders, especially those related to the metabolic syndrome. More recently, our group and others have extended the functions of FXR to more than metabolic regulation, which include anti-bacterial growth in intestine, liver regeneration, and hepatocarcinogenesis. These new findings suggest that FXR has much broader roles than previously thought, and also highlight FXR as a drug target for multiple diseases. This review summarizes the basic information of FXR but focuses on its new functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18825165     DOI: 10.1038/cr.2008.289

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  114 in total

1.  A novel heterozygous NR1H4 termination codon mutation in idiopathic infantile cholestasis.

Authors:  Xiu-Qi Chen; Lin-Lin Wang; Qing-Wen Shan; Qing Tang; Ya-Nan Deng; Shu-Jun Lian; Xiang Yun
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

2.  Farnesoid X receptor represses matrix metalloproteinase 7 expression, revealing this regulatory axis as a promising therapeutic target in colon cancer.

Authors:  Zhongsheng Peng; Jiayan Chen; Cinthia B Drachenberg; Jean-Pierre Raufman; Guofeng Xie
Journal:  J Biol Chem       Date:  2019-04-09       Impact factor: 5.157

3.  The role of nuclear receptors in the kidney in obesity and metabolic syndrome.

Authors:  Claudia Tovar-Palacio; Nimbe Torres; Andrea Diaz-Villaseñor; Armando R Tovar
Journal:  Genes Nutr       Date:  2012-04-25       Impact factor: 5.523

Review 4.  Liver x receptors in atherosclerosis and inflammation.

Authors:  Seung-Soon Im; Timothy F Osborne
Journal:  Circ Res       Date:  2011-04-15       Impact factor: 17.367

Review 5.  Sterol regulation of metabolism, homeostasis, and development.

Authors:  Joshua Wollam; Adam Antebi
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

6.  Farnesoid X receptor directly regulates xenobiotic detoxification genes in the long-lived Little mice.

Authors:  Yanjun Jiang; Jingling Jin; Polina Iakova; Julio Cesar Hernandez; Nicole Jawanmardi; Emily Sullivan; Grace L Guo; Nikolai A Timchenko; Gretchen J Darlington
Journal:  Mech Ageing Dev       Date:  2013-09-02       Impact factor: 5.432

7.  Obesity treatment by epigallocatechin-3-gallate-regulated bile acid signaling and its enriched Akkermansia muciniphila.

Authors:  Lili Sheng; Prasant Kumar Jena; Hui-Xin Liu; Ying Hu; Nidhi Nagar; Denise N Bronner; Matthew L Settles; Andreas J Bäumler; Yu-Jui Yvonne Wan
Journal:  FASEB J       Date:  2018-06-08       Impact factor: 5.191

Review 8.  Blood-Bile Barrier: Morphology, Regulation, and Pathophysiology.

Authors:  Tirthadipa Pradhan-Sundd; Satdarshan Pal Monga
Journal:  Gene Expr       Date:  2019-01-15

9.  Ligand binding and heterodimerization with retinoid X receptor α (RXRα) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding.

Authors:  Na Wang; Qingan Zou; Jinxin Xu; Jiancun Zhang; Jinsong Liu
Journal:  J Biol Chem       Date:  2018-10-01       Impact factor: 5.157

10.  Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice.

Authors:  Xiaoyan Zhang; Shizheng Huang; Min Gao; Jia Liu; Xiao Jia; Qifei Han; Senfeng Zheng; Yifei Miao; Shuo Li; Haoyu Weng; Xuan Xia; Shengnan Du; Wanfu Wu; Jan-Åke Gustafsson; Youfei Guan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.